CONFERENCE UPDATE: ACC 2023
Apixaban proves to be more effective than LMWH and equally safe in thetreatment of cancer-associated VTE
11 May 2023
CONFERENCE UPDATE: ACC 2023
Apixaban proves to be more effective than LMWH and equally safe in thetreatment of cancer-associated VTE